Articles citing this paper
Quipazine: Classical hallucinogen? Novel psychedelic?
Richard A. Glennon A * and Maƚgorzata Dukat AA Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Box 23298, Richmond, VA 23298, USA.
Richard A. Glennon: Following BSc (Pharmacy) and MSc (Medicinal Chemistry) degrees from Northeastern University, he subsequently received his PhD (Medicinal Chemistry) from the State University of New York (SUNY; Buffalo) and obtained an NIH postdoctoral fellowship in psychopharmacology (School of Medicine; SUNY). He joined the Department of Medicinal Chemistry at Virginia Commonwealth University (VCU) as Assistant Professor and eventually achieved the rank of Professor. During his tenure, he served as Department Chair, was Alfred and Frances Burger Distinguished Professor of Medicinal Chemistry and received several honors including induction into the ACS Medicinal Chemistry Hall of Fame. He currently holds an Emeritus Professor position at VCU. |
Maƚgorzata Dukat: Subsequent to an engineering (MSc Engineering) degree from T. Kosciuszko Technical University, she obtained her PhD from the prestigious Nicolaus Copernicus Academy of Medicine, Jagiellonian University, Krakow, Poland, and conducted her research at the Institute of Pharmacology, Polish Academy of Science, Krakow. After postdoctoral training in the Department of Medicinal Chemistry, School of Pharmacy and the Department of Pharmacology and Toxicology, School of Medicine at Virginia Commonwealth University (VCU), she was appointed Assistant Professor in the Department of Medicinal Chemistry at VCU where she is currently Associate Professor. She has received several distinctions including the Kosciuszko Eminent Scientist award. |
Australian Journal of Chemistry 76(5) 288-298 https://doi.org/10.1071/CH22256
Submitted: 4 December 2022 Accepted: 28 February 2023 Published: 2 May 2023